XML 41 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
(LOSS) EARNINGS PER SHARE
 12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
(LOSS) EARNINGS PER SHARE
(LOSS) EARNINGS PER SHARE
(Loss) earnings per share attributable to Bausch Health Companies Inc. for 2019, 2018 and 2017 were calculated as follows:
(in millions, except per share amounts)
 
2019
 
2018
 
2017
Net (loss) income attributable to Bausch Health Companies Inc.
 
$
(1,788
)
 
$
(4,148
)
 
$
2,404

 
 
 
 
 
 
 
Basic weighted-average number of common shares outstanding
 
352.1

 
351.3

 
350.2

Dilutive effect of stock options, RSUs and other
 
—

 
—

 
1.6

Diluted weighted-average number of common shares outstanding
 
352.1

 
351.3

 
351.8

 
 
 
 
 
 
 
(Loss) earnings per share attributable to Bausch Health Companies Inc.
 
 
 
 
 
 
Basic
 
$
(5.08
)
 
$
(11.81
)
 
$
6.86

Diluted
 
$
(5.08
)
 
$
(11.81
)
 
$
6.83


In 2019 and 2018, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 5,106,000 and 3,763,000 common shares for 2019 and 2018, respectively.
Additionally, in 2019, 2018 and 2017, stock options, time-based RSUs and performance-based RSUs to purchase approximately 2,598,000, 4,185,000 and 7,050,000 common shares of the Company, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.